Whispp, a company originally developing assistive technology for people with speech impairments, has raised €5 million in funding from LUMO Labs. The startup is now pivoting its business model toward licensing its underlying technology to device manufacturers, moving away from direct consumer products.
The investment round, structured as a €5 million deal, was led entirely by LUMO Labs, a venture firm known for backing deep-tech and impact-driven startups. Financial details beyond the round size were not disclosed, and no other investors were named in the announcement.
This pivot places Whispp in a growing market for speech-enabling technology, where licensing intellectual property to hardware makers offers a scalable revenue path. Competitors include larger firms like Google and Amazon, which offer text-to-speech APIs, but Whispp’s niche focus on aiding those with speech disorders may carve out a specialized segment. The company has not shared specific traction metrics or market size estimates.
The shift signals a broader trend among assistive-tech startups moving from direct-to-consumer models toward B2B licensing arrangements, which often yield higher margins and faster adoption. Investors may watch whether Whispp can maintain its mission-driven edge while navigating corporate partnerships.
Founder Joris Castermans, who experienced stuttering as a child and faced social isolation in high school, built Whispp out of personal frustration, giving the company an authentic origin story often cited by the firm. LUMO Labs expressed confidence in the team's ability to execute the pivot, though no direct quotes were provided.